Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022;400(10365):1803–20.

Article  PubMed  Google Scholar 

Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H, Lindstedt PA. Global regional, national burden of diabetes: from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203–34.

Article  Google Scholar 

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Magliano DJ, Boyko EJ. Committee IDFDAtes: IDF Diabetes Atlas. Idf Diabetes Atlas. Brussels: International Diabetes Federation © International Diabetes Federation; 2021.

Zheng X, Zhang X, Han Y, Hu H, Cao C. Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol. 2023;22(1):205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Won KB, Heo R, Park HB, Lee BK, Lin FY, Hadamitzky M, Kim YJ, Sung JM, Conte E, Andreini D, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46–51.

Article  CAS  PubMed  Google Scholar 

Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–8.

Article  PubMed  Google Scholar 

Tan M, Zhang Y, Jin L, Wang Y, Cui W, Nasifu L, He B. Association between atherogenic index of plasma and prehypertension or hypertension among normoglycemia subjects in a Japan population: a cross-sectional study. Lipids Health Dis. 2023;22(1):87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu X, Yu L, Zhou H, Ma Q, Zhou X, Lei T, Hu J, Xu W, Yi N, Lei S. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis. 2018;17(1):37.

Article  PubMed  PubMed Central  Google Scholar 

Li YW, Kao TW, Chang PK, Chen WL, Wu LW. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11(1):9900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, Gao F, Yang L, Xu Y, Wu Y, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Qiu W, Yang H, Chen YJ, Liu J, Zhao G. Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states. Cardiovasc Diabetol. 2024;23(1):76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin J, Li H, Wan Q. A cross-sectional study of the correlation between the Atherogenic Index of plasma and nonalcoholic fatty liver disease in patients with type 2 diabetes. Diabetes Metab Syndr Obes: Targets Ther. 2022;15:2227–34.

Article  Google Scholar 

Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–25.

Article  PubMed  Google Scholar 

Lee SW, Son JY, Kim JM, Hwang SS, Han JS, Heo NJ. Body fat distribution is more predictive of all-cause mortality than overall adiposity. Diabetes Obes Metab. 2018;20(1):141–7.

Article  CAS  PubMed  Google Scholar 

Hansen SEJ, Madsen CM, Varbo A, Nordestgaard BG. Low-Grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of Acute Pancreatitis: a study of more than 115000 individuals from the General Population. Clin Chem. 2019;65(2):321–32.

Article  CAS  PubMed  Google Scholar 

Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J Clin Investig. 2017;127(1):14–23.

Article  PubMed  PubMed Central  Google Scholar 

Bertoni AG, Burke GL, Owusu JA, Carnethon MR, Vaidya D, Barr RG, Jenny NS, Ouyang P, Rotter JI. Inflammation and the incidence of type 2 diabetes: the multi-ethnic study of atherosclerosis (MESA). Diabetes Care. 2010;33(4):804–10.

Article  PubMed  PubMed Central  Google Scholar 

Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127(1):1–4.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(Suppl 1):S11-66.

Article  Google Scholar 

Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci: BES. 2002;15(1):83–96.

PubMed  Google Scholar 

Zhang M, Shi Y, Zhou B, Huang Z, Zhao Z, Li C, Zhang X, Han G, Peng K, Li X, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey. BMJ (Clinical Res ed). 2023;380:e071952.

Google Scholar 

Sun C, Xiao X, Yan L, Sheng L, Wang Q, Jiang P, Lian M, Li Y, Wei Y, Zhang J, et al. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker? J Autoimmun. 2019;99:33–8.

Article  CAS  PubMed  Google Scholar 

Jakubiak GK, Cieślar G, Stanek A, Nitrotyrosine. Nitrated lipoproteins, and cardiovascular dysfunction in patients with type 2 diabetes: what do we know and what remains to be explained? Antioxidants (Basel, Switzerland). 2022;11(5):856.

CAS  PubMed  Google Scholar 

Lan Y, Chen G, Wu D, Ding X, Huang Z, Wang X, Balmer L, Li X, Song M, Wang W, et al. Temporal relationship between atherogenic dyslipidemia and inflammation and their joint cumulative effect on type 2 diabetes onset: a longitudinal cohort study. BMC Med. 2023;21(1):31.

Article  PubMed  PubMed Central  Google Scholar 

Yi Q, Ren Z, Bai G, Zhu S, Li S, Li C, Wu H, Zhu Y, Song P. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese. Acta Diabetol. 2022;59(2):269–79.

Article  CAS  PubMed  Google Scholar 

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med. 2013;273(6):595–601.

Article  CAS  PubMed  Google Scholar 

Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, Wang Y, Tai S. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, Peng YG. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort. BMJ open. 2021;11(5):e042821.

Article  PubMed  PubMed Central  Google Scholar 

Manell H, Kristinsson H, Kullberg J, Ubhayasekera SJK, Mörwald K, Staaf J, Cadamuro J, Zsoldos F, Göpel S, Sargsyan E, et al. Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance. Pediatr Diabetes. 2019;20(7):880–91.

Article